(Q43112877)

English

Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change

scientific article published on 31 March 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 November 2017

Exposure-response analyses of the effects of pregabalin in patients with fibromyalgia using daily pain scores and patient global impression of change (English)

1 reference

Europe PubMed Central

14 November 2017

0 references

author name string

Wonkyung Byon

1

1 reference

Europe PubMed Central

14 November 2017

Daniele Ouellet

2

1 reference

Europe PubMed Central

14 November 2017

Marci Chew

3

1 reference

Europe PubMed Central

14 November 2017

Kaori Ito

4

1 reference

Europe PubMed Central

14 November 2017

Paula Burger

5

1 reference

Europe PubMed Central

14 November 2017

Lynne Pauer

6

1 reference

Europe PubMed Central

14 November 2017

Bernhardt Zeiher

7

1 reference

Europe PubMed Central

14 November 2017

Brian Corrigan

8

1 reference

Europe PubMed Central

14 November 2017

publication date

31 March 2010

1 reference

Europe PubMed Central

14 November 2017

The Journal of Clinical Pharmacology

1 reference

Europe PubMed Central

14 November 2017

50

1 reference

Europe PubMed Central

14 November 2017

7

1 reference

Europe PubMed Central

14 November 2017

803-815

1 reference

Europe PubMed Central

14 November 2017

Fibromyalgia syndrome. An emerging but controversial condition

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Inhibition of neuronal Ca(2+) influx by gabapentin and pregabalin in the human neocortex

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pregabalin reduces the release of synaptic vesicles from cultured hippocampal neurons.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Ca2+ channel alpha2delta ligands: novel modulators of neurotransmission

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Fibromyalgia relapse evaluation and efficacy for durability of meaningful relief (FREEDOM): a 6-month, double-blind, placebo-controlled trial with pregabalin

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pharmacokinetics of pregabalin in subjects with various degrees of renal function

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pregabalin pharmacology and its relevance to clinical practice

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

A 14-week, randomized, double-blinded, placebo-controlled monotherapy trial of pregabalin in patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Prediction of creatinine clearance from serum creatinine

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Pharmacodynamics in older adults: a review

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Influence of age and gender on the pharmacokinetics and pharmacodynamics of remifentanil. I. Model development.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Sex differences in opioid analgesia: clinical and experimental findings.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Kappa-opioids produce significantly greater analgesia in women than in men.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

The kappa opioid nalbuphine produces gender- and dose-dependent analgesia and antianalgesia in patients with postoperative pain

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Fibromyalgia syndrome in men.

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Neglected topics in chronic pain treatment outcome studies: determination of success

1 reference

https://api.crossref.org/works/10.1177%2F0091270009352187

21 January 2018

Identifiers

10.1177/0091270009352187

1 reference

Europe PubMed Central

14 November 2017

1 reference

Europe PubMed Central

14 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43112877&oldid=1981189945"